Nanosize carriers for drug and vaccine delivery: Advances and challenges

被引：0
作者：
Singh A.K. [1 ]
Yadav T.P. [2 ]
Singh G. [3 ]
Pritam M. [3 ]
Pandey B. [1 ]
Ansari M.I. [4 ]
Srivastava J.K. [3 ]
Singh S.P. [1 ]
机构：
[1] Department of Biotechnology, School of Life Sciences, Mahatma Gandhi Central University, Motihari
[2] Department of Physics, Institute of Science, Banaras Hindu University, Varanasi
[3] Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Lucknow
[4] Department of Botany, University of Lucknow, Lucknow
来源：
Nanoscience and Nanotechnology - Asia | 2021年 / 11卷 / 06期
关键词：
Antigen; Drug delivery system; Nanobiotechnolgy; Nanomaterials; Nanomedicine; Vaccine;
D O I：
10.2174/2210681211666210505115217
中图分类号：
学科分类号：
摘要：
Nanomedicine has emerged as a lucrative option, attracting the attention of scientific and industrial stalwarts for its enormous potential and new business opportunities in the health sec¬tor. It encompasses physical, chemical, and biological interventions used for the transformation of bulk materials into nanomaterials (NMs) with particles size ~ 1-100 nm for highly specific medical applications. Therefore, its effects in diagnosis, efficacy, treatment and prevention of diseases may easily be foreseen. The credit goes to nanotechnology, which has emerged with the ability to ma¬nipulate the NMs concerning size, shape, composition as well as surface characteristics. Due to the advantages of their tiny size as well as novel properties, NMs are useful for loading more drugs with controlled release and specific targeting. Although full bloom of nanomedicine realization might take years, recent innovations in formulations of nanotechnology-based smart drug/vaccine delivery systems are beginning to change the landscape of future medicines. They are being de¬signed to overcome biological barriers in the living systems by improving the delivery and efficacy of traditional therapeutics and reducing the toxicity by specificity to target cells/tissues. This re¬view focuses on basic understanding and progress in the field of nanomedicine (especially nanocarriers-based drug and vaccine delivery), including nanoformulation of Amphotericin B with functionalized carbon nanotubes for the therapy of visceral leishmaniasis. © 2021 Bentham Science Publishers.
引用
收藏
相关论文
共 170 条
  • [1] Karthivashan G., Ganesan P., Park S.Y., Kim J.S., Choi D.K., Therapeutic strategies and nano-drug delivery applications in man¬agement of ageing Alzheimer’s disease, Drug Deliv, 25, 1, pp. 307-320, (2018)
  • [2] Din F.U., Aman W., Ullah I., Qureshi O.S., Mustapha O., Shafique S., Zeb A., Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors, Int. J. Nanomedicine, 12, pp. 7291-7309, (2017)
  • [3] Lammers T., Aime S., Hennink W.E., Storm G., Kiessling F., Theranostic nanomedicine, Acc. Chem. Res, 44, 10, pp. 1029-1038, (2011)
  • [4] Safari J., Zarnegar Z., Advanced drug delivery systems: Nano¬technology of health design A review, J. Saudi Chem. Soc, 18, 2, pp. 85-99, (2014)
  • [5] Luo D., Carter K.A., Lovell J.F., Nanomedical engineering: Shap¬ing future nanomedicines, Wiley Interdiscip. Rev. Nanomed. Nano- biotechnol, 7, 2, pp. 169-188, (2015)
  • [6] Swierczewska M., Crist R.M., McNeil S.E., Evaluating nanomed¬ icines: Obstacles and advancements, Characterization of Nano¬particles Intended for Drug Delivery, pp. 3-16, (2018)
  • [7] Lam P.L., Wong W.Y., Bian Z., Chui C.H., Gambari R., Recent advances in green nanoparticulate systems for drug delivery: Effi¬cient delivery and safety concern, Nanomedicine (Lond.), 12, 4, pp. 357-385, (2017)
  • [8] Singh A.K., Pal P., Gupta V., Yadav T.P., Gupta V., Singh S.P., Green synthesis, characterization and antimicrobial activity of zinc oxide quantum dots using Eclipta alba, Mater. Chem. Phys, 203, pp. 40-48, (2018)
  • [9] Corbo C., Cromer W.E., Molinaro R., Toledano Furman N.E., Hartman K.A., De Rosa E., Boada C., Wang X., Zawieja D.C., Agostini M., Salvatore F., Abraham B.P., Tasciotti E., Engi¬ neered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases, Na¬noscale, 9, 38, pp. 14581-14591, (2017)
  • [10] Jahangirian H., Lemraski E.G., Webster T.J., Rafiee- Moghaddam R., Abdollahi Y., A review of drug delivery systems based on nanotechnology and green chemistry: Green nanomedi¬cine, Int. J. Nanomedicine, 12, pp. 2957-2978, (2017)
12345678910